BCIwiki — Brain-computer interface news, research and industry database

Why it matters The project moves China's implantable BCI race into manufacturing validation, where on-time commissioning and medical-device quality compliance will matter more than announced capacity.

Why it matters Calibration-free operation is one of the key thresholds for non-invasive BCIs to leave the lab, and the drop from cross-session to cross-subject accuracy shows that handing the system to a new user remains the hard part. Real-time online control performance has not been reported.

Why it matters Intraoperative neuromonitoring is the reimbursed, high-volume end of neural signal recording, and clearances like this are a reminder that most commercial revenue in the field still comes from the operating room rather than from implanted BCIs.

Why it matters Separate registrations for the hardware and software define a narrow pediatric ADHD rehabilitation use and draw a regulatory line between the medical edition and general attention-training products.

Why it matters Moving from seizure detection to a delirium assessment aid takes Ceribell from flagging an electrical event to scoring a mental state, a materially broader claim and the reason the neuropsychiatric assessment-aid category is worth watching.

Why it matters Until now BCI surgery in China had no billable service code; costs were absorbed by research grants and company support, and patients never saw a price. The Hubei schedule issued in March 2025 put numbers on three steps for the first time — 6,552 yuan to implant an invasive system, 3,139 yuan to remove one, 966 yuan to fit a non-invasive one — and this is the first case billed against it. Three things need separating: setting a price, billing against it, and insurance reimbursement are successive stages, and only the first two have happened. This patient did not in fact pay the 6,552 yuan; research funding covered it. Chinese outlets widely headlined the case as the first "insurance-priced" BCI operation, whereas the regulator's own wording is a state-set guide price, which is a full stage short of reimbursement. It is also one of the few Chinese clinical BCI cases where an official release names both the manufacturer and the channel count.

Why it matters With no normative database behind it, the software makes no population comparison and leaves the interpretive work with the reading clinician, which is the practical line between the two quantitative EEG categories the FDA recognizes.

Why it matters The only provincial BCI document with no quantitative targets, its value lies entirely in institutional plumbing. It was the first to propose mutual recognition of clinical ethics review, and six months later the provincial health commission issued implementing guidelines with hard deadlines, completing a rare mechanism-to-rulebook loop.

Why it matters Reduced-montage EEG is the design point where clinical-grade recording and wearable hardware converge, and clearance is what separates a device a neurologist can act on from a consumer headband.

Why it matters A date-anchored regulatory record: the K number, decision date and device classification together fix how FDA currently treats automated seizure detection on full-montage EEG, a baseline for comparing later clearances on the same pathway.